IDENTIFICATION OF CD36 AS THE FIRST GENE DEPENDENT ON THE B-CELL DIFFERENTIATION FACTOR OCT-2

被引:75
作者
KONIG, H
PFISTERER, P
CORCORAN, LM
WIRTH, T
机构
[1] ZENTRUM MOLEK BIOL HEIDELBERG, D-69120 HEIDELBERG, GERMANY
[2] ROYAL MELBOURNE HOSP, WALTER & ELIZA HALL INST MED RES, MELBOURNE, VIC 3050, AUSTRALIA
关键词
B CELL; CD36; OCT-2; SUBTRACTIVE CDNA; CLONING; TARGET GENE;
D O I
10.1101/gad.9.13.1598
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The Oct-2 transcription factor is expressed predominantly in B lymphocytes and has been shown previously to be important for the terminal phase of B-cell differentiation in mice. A number of genes specifically expressed in B cells contain Oct-2-binding sites in their regulatory regions. However, the analysis of expression levels of these genes in Oct-2-deficient B cells revealed that they were unaffected. Hence, there were no genes known that critically depend on Oct-2 for their expression. To understand the molecular basis for the Oct-2 effect on B-cell development, we searched for Oct-2 target genes by subtractive cDNA cloning. We show here that expression of the murine CD36 gene in B cells and macrophages requires a functional Oct-2 protein. Nuclear run-on experiments demonstrate that this gene is regulated transcriptionally by Oct-2. Moreover, CD36 levels correlated with the levels of Oct-2 expression in several mouse B-cell and macrophage cell lines. finally, compared to wild-type and heterozygous mice, CD36 mRNA levels were markedly reduced in spleens and B cell-enriched splenocyte fractions from oct-2(-/-) mice. The data identify CD36 as the first target gene critically dependent on Oct-2 for its expression. Because CD36 expression is also dependent on Oct-2 in vivo, it is a candidate gene through which Oct-2 could affect B-cell differentiation.
引用
收藏
页码:1598 / 1607
页数:10
相关论文
共 61 条
  • [1] ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665
  • [2] IDENTICAL FORMS OF THE CD2 ANTIGEN EXPRESSED BY MOUSE LYMPHOCYTE-T AND LYMPHOCYTE-B
    ALTEVOGT, P
    MICHAELIS, M
    KYEWSKI, B
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1989, 19 (08) : 1509 - 1512
  • [3] ANNWEILER A, 1993, J BIOL CHEM, V268, P2525
  • [4] FUNCTIONAL-ANALYSIS OF DEFINED MUTATIONS IN THE IMMUNOGLOBULIN HEAVY-CHAIN ENHANCER IN TRANSGENIC MICE
    ANNWEILER, A
    MULLER, U
    WIRTH, T
    [J]. NUCLEIC ACIDS RESEARCH, 1992, 20 (07) : 1503 - 1509
  • [5] THROMBOSPONDIN SEQUENCE MOTIF (CSVTCG) IS RESPONSIBLE FOR CD36-BINDING
    ASCH, AS
    SILBIGER, S
    HEIMER, E
    NACHMAN, RL
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 182 (03) : 1208 - 1217
  • [6] ISOLATION OF THE THROMBOSPONDIN MEMBRANE-RECEPTOR
    ASCH, AS
    BARNWELL, J
    SILVERSTEIN, RL
    NACHMAN, RL
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1987, 79 (04) : 1054 - 1061
  • [7] Ausubel F. M., 1989, CURRENT PROTOCOLS MO, V1
  • [8] A HUMAN 88-KD MEMBRANE GLYCOPROTEIN (CD36) FUNCTIONS INVITRO AS A RECEPTOR FOR A CYTOADHERENCE LIGAND ON PLASMODIUM-FALCIPARUM-INFECTED ERYTHROCYTES
    BARNWELL, JW
    ASCH, AS
    NACHMAN, RL
    YAMAYA, M
    AIKAWA, M
    INGRAVALLO, P
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (03) : 765 - 772
  • [9] SRC-RELATED PROTEIN-TYROSINE KINASES ARE PHYSICALLY ASSOCIATED WITH THE SURFACE-ANTIGEN CD36 IN HUMAN DERMAL MICROVASCULAR ENDOTHELIAL-CELLS
    BULL, HA
    BRICKELL, PM
    DOWD, PM
    [J]. FEBS LETTERS, 1994, 351 (01) : 41 - 44
  • [10] GENOMIC SEQUENCING
    CHURCH, GM
    GILBERT, W
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (07): : 1991 - 1995